Abstract: This invention relates to a distributed speech recognition method comprising at least one user terminal and at least one server which can communicate with each other by means of a telecommunication network. The inventive method comprises the following steps consisting in: at the user terminal, attempting to associate a saved form with the signal to be recognized and, independently of said step, transmitting a signal to the server, indicating the signal to be recognized; and, at the server, attempting to associate a saved form with the signal received.

Abstract: This invention relates to a distributed speech recognition method comprising at least one user terminal and at least one server which can communicate with each other by means of a telecommunication network. The inventive method comprises the following steps consisting in: at the user terminal, attempting to associate a saved form with the signal to be recognized and, independently of said step, transmitting a signal to the server, indicating the signal to be recognized; and, at the server, attempting to associate a saved form with the signal received.

Abstract: This invention relates to a distributed speech recognition system. The inventive system consists of: at least one user terminal comprising means for obtaining an audio signal to be recognized, parameter calculation means and control means which are used to select a signal to be transmitted; and a server comprising means for receiving the signal, parameter calculation means, recognition means and control means which are used to control the calculation means and the recognition means according to the signal received.

Abstract: Coated compressed tablets for oral administration are disclosed which substantially desintegrate specifically at the level of the colon. The tablets comprise a compressed center piece containing an active agent which center piece is coated by a first coating layer which is comprised of a mixture of a pharmaceutically acceptable film-forming organic polymer material which is non-deteriorated by a neutral or alkaline aqueous medium and microcrystalline cellulose and a second coating layer which is comprised of a pharmaceutically acceptable enteric organic polymer coating material.